pharmaphorum
JANUARY 5, 2023
Bioethics International has developed a benchmarking tool for “fair inclusion” in clinical trials, drawing on pivotal trials submitted to the FDA in support of 59 new cancer therapeutics – submitted by 25 sponsors – that were approved by the regulator between 2012 and 2017.
Putting Patients First Blog
NOVEMBER 14, 2023
According to a 2017 report by the National Council on Disability, individuals with disabilities often face significant barriers in accessing health care services, including discriminatory attitudes from health care.9 Medical futility and disability bias: part of the bioethics and disability series. 9 Proposed paragraph 84.56(b)(1)(i)
STAT
MARCH 6, 2023
”It’s imprudent and unwise and not the way forward, even for people who are very ill,” said Dr. Arthur Caplan, a professor of bioethics at the NYU Langone hospital system in New York who chaired a university panel that studied the FDA’s compassionate use program.
Expert insights. Personalized for you.
75 
Let's personalize your content